What We Do
YouthBio is at the forefront of developing tissue-specific gene therapies that leverage partial cellular reprogramming to rejuvenate tissues, enhance organ function, and prevent age-related diseases. Our primary objective is to restore a more youthful gene expression profile in targeted cells, resulting in improved function of corresponding organs and beneficial therapeutic effects in diseases associated with those organs.

Our Long-term Vision
We envision a future where a combination therapy can periodically rejuvenate multiple key organs, leading to systemic rejuvenation and a healthier, longer life. To get there, we are presently focusing on developing organ-specific therapies that are first tested in major age-related diseases associated with those organs.

Innovative Research and Development
In addition to using canonical Yamanka factors for partial reprogramming, we are dedicated to discovering new rejuvenating factors that enhance treatment safety and efficacy. We are also developing a tissue-specific gene delivery and induction platform for our combination therapies, paving the way for more targeted and personalized treatment options.

At YouthBio, we are committed to pushing the boundaries of science to create a world where aging no longer means decline in health and quality of life. Join us on our journey to redefine the future of aging and healthcare.